Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**DPY19L4 pseudogene 1 (DPY19L4P1)** is a human pseudogene—meaning a gene copy that is non-functional due to accumulated mutations and disruptions in its coding sequence. Pseudogenes such as DPY19L4P1 originate as duplications or processed copies of their parental genes but cannot produce a functional protein because of features like premature stop codons or frame shifts[2][5]. The parental gene family (DPY19L) encodes putative transmembrane proteins related to mannosyltransferase activity in some functional family members, but as a pseudogene, DPY19L4P1 does not encode a functional enzyme and does not act as a receptor, transporter, enzyme, or other canonical druggable target[2][5]. Pseudogenes can, however, sometimes participate in regulatory functions at the RNA level, such as serving as competing endogenous RNAs (ceRNAs), but there is currently no specific evidence for regulatory, pathological, or therapeutic relevance of DPY19L4P1[2][3][5]. It is not a recognized therapeutic target, and no drugs, biomarkers, or disease associations are currently assigned to it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DPY19L4 pseudogene 1 (DPY19L4P1).